Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...

Cyclacel Pharmaceuticals, Inc. announced a 1-for-15 reverse stock split of its common stock, effective July 7, 2025, with trading commencing on a split-adjusted basis that day under the ticker symbol ...

Many investors wonder if the electric car maker’s stock will split this year. Here’s an analysis of whether this is a likely scenario to occur in 2024. Below we'll look at Tesla's stock split history, ...

Forbes contributors publish independent expert analyses and insights. Catherine Brock covers personal finance and investing. Apple (AAPL) is the second-largest company (by market cap) in the world and ...